Comparison of clinical outcomes between unrelated single umbilical cord blood and “ex-vivo” T-cell depleted haploidentical transplantation in children with hematological malignancies-Reference-Cited by-同舟云学术

Comparison of clinical outcomes between unrelated single umbilical cord blood and “ex-vivo” T-cell depleted haploidentical transplantation in children with hematological malignancies

Published:2021-09-30 Issue:6 Volume:17 Page:609-618
ISSN:1708-8569
Container-title:World Journal of Pediatrics
language:en
Short-container-title:World J Pediatr

Author:

Gómez-Santos Carmen,González-Vicent Marta,Molina Blanca,Deltoro Natalia,Herrero Blanca,Ruiz Julia,Pérez-Martínez Antonio,Diaz Miguel A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology, and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s12519-021-00461-w.pdf

Reference55 articles.

1. Mallhi K, Lum LG, Schultz KR, Yankelevich M. Hematopoietic cell transplantation and cellular therapeutics in the treatment of childhood malignancies. Pediatr Clin North Am. 2015;62:257–73.

2. Cairo MS, Rocha V, Gluckman E, Hale G, Wagner J. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors. Biol Blood Marrow Transplant. 2008;14(1 Suppl 1):44–53.

3. Gragert L, Eapen M, Williams E, et al. HLA match likelihoods for hematopoietic stem - cell grafts in the U.S. registry. N Engl J Med. 2014;371:339–48.

4. Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant. 2008;41:207–14.

5. Kekre N, Antin JH. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. Blood. 2014;124:334–43.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In 2022, which is preferred: haploidentical or cord transplant?;Hematology;2022-12-09

2. Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients;Frontiers in Oncology;2022-07-14